Efficient management of secondary haemophagocytic lymphohistiocytosis with intravenous steroids and γ-immunoglobulin infusions

BACKGROUND: Secondary haemophagocytic lymphohistiocytosis (sHLH) is a rare life-threatening condition mainly associated with underlying infections, malignancies, and autoimmune or immune-mediated diseases. AIM: To analyse all sHLH cases that were diagnosed and managed under real-world circumstances...

Descripción completa

Detalles Bibliográficos
Autores principales: Georgiadou, Sarah, Gatselis, Nikolaos K, Stefos, Aggelos, Zachou, Kalliopi, Makaritsis, Konstantinos, Rigopoulou, Eirini I, Dalekos, George N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2019
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854401/
https://www.ncbi.nlm.nih.gov/pubmed/31750324
http://dx.doi.org/10.12998/wjcc.v7.i21.3394

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854401/
https://www.ncbi.nlm.nih.gov/pubmed/31750324
http://dx.doi.org/10.12998/wjcc.v7.i21.3394

Ejemplares similares